Log in to save to my catalogue

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age...

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2861305004

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration

About this item

Full title

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Graefe's archive for clinical and experimental ophthalmology, 2024-01, Vol.262 (1), p.43-51

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
To assess 6-month outcomes of switching from aflibercept to faricimab in eyes with refractory neovascular age-related macular degeneration (nAMD) previously requiring monthly injections.
Methods
This multicenter retrospective study examined nAMD eyes receiving monthly aflibercept injections switched to faricimab administered monthl...

Alternative Titles

Full title

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2861305004

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2861305004

Other Identifiers

ISSN

0721-832X

E-ISSN

1435-702X

DOI

10.1007/s00417-023-06222-x

How to access this item